A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing three pieces of marijuana research legislation in Congress.

The Michael J. Fox Foundation (MJFF) -- named after the actor, who has Parkinson’s and established the nonprofit -- said last week that lifting barriers to cannabis research, including rescheduling the plant under the Controlled Substances Act (CSA), is necessary to promote studies verifying marijuana’s potential therapeutic benefit for conditions such as Parkinson’s patients.

Click here to read the complete article

Kyle Jaeger ~ MarijuanaMoment.net ~

Recent News Articles

Thursday December 19

Italian Government Hopes To Nearly Triple Domestic Medical Marijuana Production, Lessen Imports - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

Medical marijuana production in Italy may triple in 2020 as the government aims to lesser…

1697 hits

Thursday December 19

Massachusetts marijuana dispensary first in state to sell gift cards - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

A pot shop in Massachusetts is making history this holiday season by becoming the first…

2013 hits

Thursday December 19

Georgia: Board launches effort to deliver medical marijuana to patients - Cannabis News

in Medical

by Bruce Kennedy - Editor in Chief

A new government board started setting up ways to distribute medical marijuana oil in Georgia…

2826 hits

Thursday December 19

Veteran says VA should provide medical marijuana for vets - Cannabis News

in Activism

by Bruce Kennedy - Editor in Chief

"I see a lot of veterans that are addicted to opioids and I know that…

2758 hits

Friday December 20

Ten Pesticides Approved for Use on Industrial Hemp - Cannabis News

in CBD & Hemp

by Bruce Kennedy - Editor in Chief

With the 2020 growing season on the horizon, the EPA announced on Thursday the approval…

2800 hits